Journal of gastrointestinal cancer · 2026
Comparative Analysis of Lesion Detection and Uptake Characteristics of 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT in Gastric Cancer.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kalender Ebuzer, Yildirim Edanur Eki̇nci̇, Yerdeş Enes, Saribaş Buket Eren, Elboğa Umut, Şahi̇n Ertan, Çi̇men Vuslat Mumcu
Аннотация
PURPOSE: This study aimed to compare lesion detection and uptake characteristics of 68Ga-FAPI PET/CT and 18F-FDG PET/CT in patients undergoing imaging for gastric cancer (GC) staging.
METHODS: A total of 24 patients with histopathologically confirmed GC were retrospectively evaluated. All patients underwent 18F-FDG PET/CT followed by 68Ga-FAPI PET/CT within a short interval as part of their clinical staging workup. Lesion detection rates and semi-quantitative parameters, including SUVmax and tumor-to-background ratio (TBR), were compared between the two modalities.
RESULTS: 68Ga-FAPI PET/CT demonstrated significantly higher SUVmax values than 18F-FDG PET/CT across primary tumors and metastatic lesions (p < 0.05). TBRs were also markedly higher for FAPI due to lower physiological background activity. In patient-based analysis, 68Ga-FAPI PET/CT identified a higher number of nodal and distant metastases compared to 18F-FDG PET/CT; however, these differences did not reach statistical significance (p = 0.25). Notably, discordant findings were observed in three patients, in whom lesions-particularly peritoneal and bone metastases-were detected by 68Ga-FAPI PET/CT but not by 18F-FDG PET/CT.
CONCLUSION: 68Ga-FAPI PET/CT provides higher tracer uptake and improved TBR compared to 18F-FDG PET/CT in GC. Although lesion detection rates were numerically higher with FAPI, statistical significance was not reached in this cohort. These findings suggest a potential complementary role of FAPI PET/CT, particularly in detecting peritoneal and bone metastases and in cases with low FDG avidity. Larger prospective studies are warranted to clarify its clinical impact.
METHODS: A total of 24 patients with histopathologically confirmed GC were retrospectively evaluated. All patients underwent 18F-FDG PET/CT followed by 68Ga-FAPI PET/CT within a short interval as part of their clinical staging workup. Lesion detection rates and semi-quantitative parameters, including SUVmax and tumor-to-background ratio (TBR), were compared between the two modalities.
RESULTS: 68Ga-FAPI PET/CT demonstrated significantly higher SUVmax values than 18F-FDG PET/CT across primary tumors and metastatic lesions (p < 0.05). TBRs were also markedly higher for FAPI due to lower physiological background activity. In patient-based analysis, 68Ga-FAPI PET/CT identified a higher number of nodal and distant metastases compared to 18F-FDG PET/CT; however, these differences did not reach statistical significance (p = 0.25). Notably, discordant findings were observed in three patients, in whom lesions-particularly peritoneal and bone metastases-were detected by 68Ga-FAPI PET/CT but not by 18F-FDG PET/CT.
CONCLUSION: 68Ga-FAPI PET/CT provides higher tracer uptake and improved TBR compared to 18F-FDG PET/CT in GC. Although lesion detection rates were numerically higher with FAPI, statistical significance was not reached in this cohort. These findings suggest a potential complementary role of FAPI PET/CT, particularly in detecting peritoneal and bone metastases and in cases with low FDG avidity. Larger prospective studies are warranted to clarify its clinical impact.